Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy of a shimmering sun and deliciously cool breeze wafting across the serene Pharmalot campus. An unusual quiet has, in fact, descended upon us, since one short person is sleeping in, another has left for gainful employment, and the official mascot is holding a snoozefest. This leaves us to our usual tasks of brewing cups of stimulation and keeping busy finding interesting developments. Meanwhile, here are some tidbits to help you on your own journey. Have a good one. …

Lawyers for the state of Oklahoma urged a judge to find Johnson & Johnson (JNJ) culpable for the state opioid crisis and make the company pay $17.5 billion to help clean up the damage, the Washington Post writes. State and company lawyers delivered spirited closing arguments that capped the landmark seven-week proceeding — the first state trial in what has become a nationwide effort to recoup money from the drug industry for the cost of the crisis. Judge Thad Balkman is expected to issue a decision near the end of August.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy